NACS President and CEO to Testify on FDA Regulation

Press enter to search
Close search
Open Menu

NACS President and CEO to Testify on FDA Regulation

ALEXANDRIA, Va. -- NACS president and CEO Hank Armour will formally testify on legislation to give the U.S. Food and Drug Administration (FDA) authority over the sale of tobacco, before the House Energy and Commerce Committee's Subcommittee on Health on Oct. 3, the association stated.

The hearing will be the first opportunity for NACS to testify in the issue before the current Congress, according to NACS. The Senate Health, Education, Labor and Pensions Committee, which passed similar legislation on Aug. 1, did not allow NACS to present its views at that time, NACS stated. That bill contains two sections -- giving authority to the FDA to regulate the manufacture of tobacco and the authority over the retail sale of tobacco.

In his testimony, Armour will explain that retailers are not taking a position on the legislation's proposed regulation of the manufacture of tobacco, and instead, is concerned over the part of the legislation that would affect retailers, the association stated. In addition, Armour's testimony will discuss the changes NACS has proposed that would protect retailers, as well as improve the bill's ability to prevent the sale of tobacco to minors, according to the association.

Look for a full report on the hearing and Armour's testimony next week on CSNews Online.